TNBC Trial status Recruitment Status : Not yet
Post# of 148167
(Total Views: 195)
Posted On: 04/01/2019 8:37:25 AM
Re: ClosetInvestor #1553
TNBC Trial status
Recruitment Status : Not yet recruiting
First Posted : February 12, 2019
Last Update Posted : February 15, 2019
See Contacts and Locations
Seems they might be starting soon, but no one in the trial as of yet, but then again, not updated since Feb 15th.
I hope with the release of this press release it is soon. Seems they are already behind schedule.
Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 48 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase Ib/II Study of Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC)
Estimated Study Start Date : February 2019
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2022
Recruitment Status : Not yet recruiting
First Posted : February 12, 2019
Last Update Posted : February 15, 2019
See Contacts and Locations
Seems they might be starting soon, but no one in the trial as of yet, but then again, not updated since Feb 15th.
I hope with the release of this press release it is soon. Seems they are already behind schedule.
Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 48 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase Ib/II Study of Leronlimab (PRO 140) Combined With Carboplatin in Patients With CCR5+ Metastatic Triple Negative Breast Cancer (mTNBC)
Estimated Study Start Date : February 2019
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2022
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼